fbpx

China Cardiology KOLs Fair-Market Value Compensation Rates Report

China Cardiology KOLs Fair-Market Value Compensation Rates Report

DUBLIN -The “Fair-Market Value Compensation Rates for Cardiology KOLs – China” report has been added to ResearchAndMarkets.com’s offering.

KOL Compensation China Cardiology provides fair-market value (FMV) remuneration rates for Chinese based KOLs in Cardiology, broken out by percentiles and averages for six (6) activities and four (4) levels of Thought Leader impact.

Payments to physicians and thought leaders have been under review for several years, and firms have been attempting to bring their rates in line with industry standards. Adjustments to “market” rates should be made on a regular basis, preferably through third-party research, which provides a fair and unbiased assessment of rates.

These defensible market-based rate data are derived directly from industry salaries for Healthcare Practitioners (HCPs) and Thought Leaders. All KOL FMV rate reports represent fair-market value determined by our dependable process of gathering data from industry professionals involved in determining pay levels for exchanges with KOLs worldwide.

Establishing fair-market value compensation rates will:

  • reduce the external perception of inappropriate inducement and limit regulatory and compliance risks.
  • provide an independent reference for negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs).
  • refine and support the development of fee schedules that are aligned with market conditions.
  • competitively position the organization and support good business practices.

Each report contains an aggregate of collected data, rather than individual rates. In no case are the companies or persons who contributed the data identifiable to protect their identities.

KOL Compensation China Cardiology

Engage with thought leaders early on. According to recent study, less than 25% of pharmaceutical companies begin working with Key Opinion Leaders during or before the trial phase. Most – 63% – wait until phases 2 and 3 to begin exchanging with Thought Leaders. This is unlikely to produce the intended effects for businesses seeking to maximize the potential of any promising product.

Key Topics Covered:

  • Use of the publisher’s Copyrighted Materials
  • Research Methodology
  • Definitions
  • Therapeutic Area
  • Thought Leader Levels
  • Flat Rates
  • Hourly Rates
  • Flat Rates
  • Advisory Board Lead
  • Advisory Board Non-lead
  • Consulting Scientific/Clinical Content
  • Consulting Commercial Content
  • Speaking Scientific/Clinical Content
  • Speaking Commercial Content
  • Hourly Rates
  • Advisory Board Lead
  • Advisory Board Non-lead
  • Consulting Scientific/Clinical Content
  • Consulting Commercial Content
  • Speaking Scientific/Clinical Content
  • Speaking Commercial Content

For more information about this report visit https://www.researchandmarkets.com/r/wgir5b

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading provider of international market research studies and market data. We provide you with the most recent information on international and regional markets, significant industries, leading businesses, innovative products, and emerging trends.

2 thoughts on “China Cardiology KOLs Fair-Market Value Compensation Rates Report

  1. cakrabola
    I just like the valuable info you supply for your articles.

    I’ll bookmark your weblog and test again here regularly.
    I’m rather sure I will learn many new stuff proper
    right here! Good luck for the following!

Leave a Reply

Your email address will not be published. Required fields are marked *